The human gut microbiome produces potent ligands to bile acid receptors, and probiotics could act as therapeutics of bile acid dysmetabolism. A recent study in Cell Reports demonstrates that probiotic VSL#3 affects bile acid deconjugation and excretion, as well as the gut�liver FXR�FGF15 axis.
© 2001-2026 Fundación Dialnet · Todos los derechos reservados